Search results
Results From The WOW.Com Content Network
Vanderbilt-Ingram Cancer Center. / 36.14056°N 86.80389°W / 36.14056; -86.80389. The Vanderbilt-Ingram Cancer Center is an NCI-designated Comprehensive Cancer Center in Nashville, TN. It is part of the Vanderbilt University Medical Center . The Vanderbilt Cancer Center was established in 1993 and received its initial NCI designation in ...
The Vanderbilt-Ingram Cancer Center is one of 50 National Cancer Institute-designated cancer centers, and the only one in Tennessee that provides treatment for adult and pediatric cancers. [8] The center is also a member of the National Comprehensive Cancer Network, a non-profit alliance of 21 centers focused on improving quality and efficiency ...
W. Kimryn Rathmell (born November 3, 1969) is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She is the 17th Director of the National Cancer Institute, having previously served as the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for ...
Rathmell is an oncologist and kidney cancer expert who leads the Vanderbilt University Medical Center in Nashville, Tenn. As leader of the NCI, Rathmell… White House taps Vanderbilt oncologist ...
President Biden selected Dr. W. Kimryn Rathmell, chair of Vanderbilt University's department of medicine, to lead the National Cancel Institute.
Vanderbilt-Ingram Cancer Center at Vanderbilt University (Nashville) St. Jude Children's Research Hospital (Memphis) (independent) Texas (3): Dan L Duncan Cancer Center at Baylor College of Medicine (Houston) Harold C. Simmons Cancer Center at University of Texas Southwestern Medical Center (Dallas)
In 2020, Winkfield joined Vanderbilt University. She is the executive director of the Meharry-Vanderbilt Alliance, Ingram Professor of Cancer Research, and a professor of radiation oncology at Vanderbilt University Medical Center. Winkfield is the cofounder and director of the Association of Black Radiation Oncologists.
William Pao (born 1967) is an oncologist and Executive Vice President and Chief Development Officer of Pfizer. [1] He was previously the head of Pharma Research and Early Development (pRED) at Roche and a professor of medicine at the Vanderbilt University Medical Center. He is best known for his work in molecular oncology and cancer genomics.